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AbstrACt
Objective To systematically review the research 
conducted on prevalence of frailty and prefrailty among 
community-dwelling older adults in low-income and 
middle-income countries (LMICs) and to estimate the 
pooled prevalence of frailty and prefrailty in community-
dwelling older adults in LMICs.
Design Systematic review and meta-analysis. PROSPERO 
registration number is CRD42016036083.
Data sources MEDLINE, EMBASE, AMED, Web of Science, 
CINAHL and WHO Global Health Library were searched 
from their inception to 12 September 2017.
setting Low-income and middle-income countries.
Participants Community-dwelling older adults aged ≥60 
years.
results We screened 7057 citations and 56 studies 
were included. Forty-seven and 42 studies were included 
in the frailty and prefrailty meta-analysis, respectively. 
The majority of studies were from upper middle-income 
countries. One study was available from low-income 
countries. The prevalence of frailty varied from 3.9% 
(China) to 51.4% (Cuba) and prevalence of prefrailty 
ranged from 13.4% (Tanzania) to 71.6% (Brazil). The 
pooled prevalence of frailty was 17.4% (95% CI 14.4% 
to 20.7%, I2=99.2%) and prefrailty was 49.3% (95% 
CI 46.4% to 52.2%, I2=97.5%). The wide variation in 
prevalence rates across studies was largely explained 
by differences in frailty assessment method and the 
geographic region. These findings are for the studies with 
a minimum recruitment age 60, 65 and 70 years.
Conclusion The prevalence of frailty and prefrailty 
appears higher in community-dwelling older adults in 
upper middle-income countries compared with high-
income countries, which has important implications for 
healthcare planning. There is limited evidence on frailty 
prevalence in lower middle-income and low-income 
countries.
PrOsPErO registration number CRD42016036083.
IntrODuCtIOn  
Population ageing is not confined to 
high-income countries (HICs). People in 
low-income and middle-income countries 
(LMICs) have increasing life expectancy with 
the advancement of healthcare services.1 
The pace of population ageing is faster in 
LMICs compared with HICs.2 This creates an 
additional burden for these countries with 
growing economies as they have to tackle 
health, social and welfare issues associated 
with ageing populations.
Frailty is a health problem of older age with 
no universally agreed conceptual or opera-
tional definition. However, there is a common 
agreement that frailty is an important clin-
ically identifiable state that increases the 
vulnerability to adverse outcomes due to the 
decline in reserve and functions in multiple 
physiological systems.3 The Fried pheno-
type of frailty, comprising five phenotypic 
criteria (unintentional weight loss, self-re-
ported exhaustion, weakness, slowness and 
low physical activity),4 and the frailty index 
(comprising a list of deficits)5 are the most 
strengths and limitations of this study
 ► This is the first systematic review and meta-analysis 
of the prevalence of frailty and prefrailty among 
community-dwelling older adults in low-income and 
middle-income countries.
 ► We conducted a comprehensive literature search 
in six electronic databases with a comprehensive 
search strategy, including WHO Global Health Library 
to capture studies published regionally.
 ► No language restriction was imposed.
 ► Subgroup analysis of prevalence of frailty and 
prefrailty was performed with substantial number 
of studies, and meta-regression technique was used 
to identify the sources of heterogeneity between the 
studies.
 ► We did not include grey literature in this review.
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frequently used frailty assessment methods in the litera-
ture.6 Longitudinal studies have identified several nega-
tive outcomes associated with frailty which can have a 
huge impact on individual lives and society as a whole. 
These include falls, worsening mobility, disability, hospi-
talisation and increased risk of mortality.4 5 7 8
Prefrailty is an intermediate state between frailty and 
non-frailty/robust that has higher risk of progressing 
to frailty.9 Since frailty status is assessed using different 
assessment methods, most of the assessment methods 
have its own cut-off for prefrailty status. For instance, 
having one to two criteria of five is considered as prefrail 
for the Fried’s phenotype.4 Like frailty, prefrailty is also 
associated with adverse health outcomes. Findings from 
a recent meta-analysis based on six prospective cohort 
studies suggested increased risk for faster onset of any 
type of cardiovascular diseases in prefrail versus robust.10 
Another longitudinal study also showed that prefrail 
individuals are more likely to show persistent and new 
depressive symptoms.11 Evidence is emerging that frailty 
as a dynamic state with transitions between frailty statuses; 
frailty, prefrailty and non-frailty;12–14 and there is potential 
for interventions to improve the health and well-being of 
both frail and prefrail older adults.
A substantial amount of research on frailty has been 
conducted in HICs. According to a systematic review 
conducted in 2012, the weighted prevalence of frailty in 
HICs is 10.7% and prefrailty is 41.6%.15 There is some 
suggestion of a socioeconomic gradient in frailty between 
HICs; one study from 15 European countries reported a 
lower mean frailty index in North and Western Europe 
compared with lower income countries in South and 
Eastern Europe.16 In addition, the survival of frail older 
people was higher in countries with a higher relative 
income within Europe.16 It is possible that the prevalence 
of frailty in LMICs is higher than HICs, given a steeper 
gradient in income. Alternatively, the prevalence may be 
lower with a reduced life expectancy of older people in 
LMICs. A narrative review published in 2015 on frailty 
in developing countries found limited availability of 
studies and suggested that frailty occurs more frequently 
in developing countries.17 However, no studies are avail-
able up-to-date collating all the epidemiological findings 
available from LMICs to examine the burden of frailty in 
these countries. This is important to inform healthcare 
planning in these countries in the context of world-wide 
population ageing. The aim of this study was to conduct 
a systematic review and meta-analysis on prevalence of 
frailty and prefrailty among community-dwelling older 
adults in LMICs.
MEthODs
search strategy and selection criteria
We performed a comprehensive structured search 
in six electronic bibliographic databases. MEDLINE, 
EMBASE and AMED databases using OvidSP interface, 
Web of Science Core Collection, CINAHL Plus databases 
and WHO Global Health Library were searched from 
their inception to 12 September 2017. Two concepts 
‘frailty’ and ‘LMICs’ were used to develop the electronic 
search strategy. The example LMIC filters developed by 
the Cochrane organisation in 2012 was used with slight 
modifications.18 The World Bank country classification 
issued on 1 July 2017,19 based on 2016 economic data was 
used to identify the countries that switched from LMICs to 
HICs in 2017 or vice versa. Studies in these countries were 
included only if the country belongs to low-income and 
middle-income category during the time of data collec-
tion. The electronic search strategy was first developed 
for MEDLINE (online supplementary appendix A) and 
then adapted accordingly to other databases. The elec-
tronic search strategy was developed with the support of 
specialist librarian (SP). Additionally reference lists of the 
selected articles were scanned and citation searches were 
performed in the Web of Science. The search was limited 
to full-text articles as study quality assessment requires a 
detailed description on the methodology. No language 
restriction was imposed on the search.
The condition studied was frailty measured by any assess-
ment method. The review was restricted to studies with 
community-dwelling older adults aged ≥60 years living 
in the LMICs. This age cut-off is in line with the United 
Nations’s definition of older populations.20 Studies with 
institutionalised or hospitalised adults, nursing home resi-
dents, outpatients of primary or secondary care clinics, 
or older adults belonging to specific disease groups were 
excluded. Cross-sectional studies conducted to assess the 
prevalence and associated factors of frailty, prospective 
follow-up studies that have baseline prevalence of frailty, 
cross-sectional studies conducted to explore the associa-
tion of frailty with some other health variable or disease 
(eg, haemoglobin level and cardiovascular risk factors) 
were included in this review.
Identified citations were exported into EndNote X8 and 
duplicates were removed. In the first stage, the title and 
abstracts of the citations were screened against inclusion 
and exclusion criteria to identify potentially eligible cita-
tions. In the second stage, full texts of potentially eligible 
articles were retrieved. Two reviewers (DDS and SH) 
independently reviewed the full-text articles to identify 
the articles meeting eligibility criteria. If multiple studies 
were available from the same cohort, the study with the 
largest sample and most information was included in the 
review. The agreement between the two raters was high 
with a kappa value of 0.84 (95% CI 0.72 to 0.90). Disagree-
ment between the reviewers was resolved through discus-
sions and consulting senior researchers in the research 
team (KRW, GR and MCW).
study quality assessment and data extraction
Selected articles were subjected to a quality assessment. 
Methodological rigour of the articles was assessed using 
eight criteria proposed by Loney et al21 for the critical 
appraisal of the prevalence literature. If a study achieved 
three criteria or less, it was excluded from the review. 
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Study quality of all selected articles (61) was assessed 
by the first reviewer (DDS). The second reviewer (SH) 
assessed the study quality of a random 10% of articles to 
check for discrepancies.
Data extraction included information on study back-
ground (authors and year of publication, data source, 
study setting and study period), characteristics of the 
population (percentage of women in the study popula-
tion, mean age, age range, number of frail and prefrail 
participants in the total sample, and by sex and age), 
study methodology (study design, effective sample, 
sampling technique and frailty assessment method) and 
study strengths and limitations. Authors were contacted 
requesting additional data required for subgroup analysis.
Data analysis
The results of the systematic review are presented in 
tabular format and narratively synthesised. All statistical 
analyses were performed in Stata V.14 (StataCorp, College 
Station, Texas, USA). A random-effects meta-analysis with 
95% CI was performed to calculate the pooled preva-
lence of frailty and prefrailty. A random-effects model 
was chosen as there is a variation in the true effect from 
one study to another. And also, there was considerable 
heterogeneity of the study characteristics including 
geography, frailty assessment method, frailty cut-offs and 
recruitment age. When a study has used multiple assess-
ment methods of frailty, the prevalence presented using 
Fried phenotype was used for the meta-analysis as it was 
the most commonly used assessment method in the liter-
ature.22 The analysis was performed on Freeman-Tukey 
double arcsine transformed proportions to stabilise the 
variance. We used metaprop random ftt command.23 Results 
were presented using forest plots. The main meta-analysis 
and subgroup analysis excluded three studies, two studies 
with minimum recruitment age of ≥80 years and another 
study with minimum recruitment age of ≥90 years as 
those based on much older populations with expected 
higher prevalence rates for frailty. The findings from 
these studies were reported separately.
Cochran’s Q statistic was used to assess heterogeneity 
between the studies. P<0.05 was considered as evidence 
of heterogeneity. The I2 statistic was further used to quan-
tify the magnitude of the heterogeneity. I2 values of 25%, 
50% and 75% were considered as of low, moderate and 
high heterogeneity, respectively.24 Funnel plots gener-
ated by metafunnel command was used to visually inspect 
the existence of reporting biases and/or between study 
heterogeneity. In the absence of biases and/or between 
study heterogeneity, funnel plot will be a symmetrical 
inverted funnel in shape.25 However, this eye ball test is 
subjective. Hence, we used Egger's weighted regression 
test to measure the degree of funnel plot asymmetry. The 
null hypothesis for Egger’s test is that symmetry exists in 
the funnel plot.26 27 Stata metabias command was used.
Subgroup analysis of frailty and prefrailty preva-
lence was performed according to the frailty assess-
ment method (Fried phenotype with five criteria where 
weakness and slowness assessed objectively using grip 
strength and gait speed, Fried phenotype with five criteria 
where weakness and slowness assessed using self-re-
ported questions (subjective), Fried phenotype with 
four criteria, Edmonton Frail Scale (EFS), frailty index 
and FRAIL scale). If the same cohort of participants had 
been assessed using different frailty assessment methods, 
we used that information in the subgroup analysis. 
However, studies that have used different frailty assess-
ment methods to that mentioned above were excluded 
from the frailty and prefrailty subgroup analysis as they 
cannot be grouped into a particular category that is Study 
of Osteoporotic Fractures (SOF) index and Cuban frailty 
criteria, Brief Frailty Instrument for Tanzania (B-FIT). 
Further subgroup analyses by sex, age group (60–64, 
65–69, 70–74, 75–79, 80–84, 85+ years), age and sex were 
performed with studies which had employed the Fried 
phenotype with five criteria where weakness and slowness 
assessed using objective tests. A two-sample proportion 
test was used to compare the prevalence of frailty and 
prefrailty by sex.
We performed a supplementary analysis to compare 
our findings with HICs. We used published data from a 
systematic review on prevalence of frailty which includes 
HICs only.15 This review included 14 studies which had 
used Fried’s phenotype of frailty assessment method. 
We estimated the random-effects pooled prevalence of 
frailty and prefrailty only with the studies that have used 
the Fried phenotype with five criteria where weakness 
and slowness assessed using objective tests (10 studies). 
Minimum recruitment age of the participants included in 
this review was 65 years. For a fair comparison we calcu-
lated the random-effects pooled prevalence of frailty and 
prefrailty only with the studies of minimum recruitment 
age 65 years that have used same assessment method 
included in our review.
Random-effects univariable and multivariable meta-re-
gression were performed using metareg command to 
identify the potential sources of heterogeneity between 
the studies (demographic, geographical and method-
ological).28 Three studies which used SOF index, Cuban 
frailty criteria and Brief Frailty Instrument for Tanzania 
(B-FIT) were excluded from the analysis. The following 
explanatory variables were included in the models; mean 
age, percentage of women in the study sample, study 
quality assessment score, World Bank region classifica-
tion (Latin America and the Caribbean, East Asia and 
Pacific, Europe and Central Asia, and South Asia) and 
frailty assessment method. All the variables were included 
in the multivariable model irrespective of their signifi-
cance (P value) in univariable analysis. Variables with 
P<0.05 were considered as significant. The systematic 
review protocol of this study is registered in PROSPERO 
and the number is CRD42016036083. This systematic 
review and meta-analysis have been reported according 
to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA 2009 checklist is attached 
separately).29
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rEsults
study characteristics
The search yielded 10 253 records, with 7057 records left 
after removing duplicates. Fifty-six studies meeting all 
eligibility criteria were included in the systematic review 
(figure 1). Forty-seven and 42 studies were included in 
the meta-analysis of frailty and prefrailty, respectively.
The study quality assessment score of the studies 
included ranged from 3.5 to 7.5, with a mean score of 
(SD) 6.0 (1.07). Quality assessment results of the studies 
are presented in the online supplementary appendix B. 
The characteristics of included studies are described in 
the online supplementary appendix C. Fifty studies have 
been published between 2012 and 2017. The majority of 
the studies were from the Latin America and the Carib-
bean region, predominantly from Brazil (n=24). Most of 
the studies had used data from large population-based 
cross-sectional or longitudinal studies on ageing.
The sample size of the studies varied (range 54–12 373) 
and the minimum recruitment age of the study partici-
pants varied from 60 to 90 years. The minimum age at 
recruitment of the study participants was 60 years in 30 
Figure 1 Study selection.
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studies, 65 years in 19 studies, 70 years in 4 studies, 80 
years in 2 studies and 90 years in 1 study. Fifty-two studies 
had reported the percentage of women in the study 
samples and it varied from 48.1% to 100.0%, with more 
than half of participants being women in all except three 
studies. Forty-two studies reported the mean age (42/56) 
of the participants, which ranged from 68.2 to 77.2 years 
after excluding three studies with minimum recruitment 
age ≥80 years (two studies) and ≥90 years (one study).
Studies used various frailty assessment methods. The 
Fried phenotype was the most extensively used method. 
Researchers had operationalised the Fried phenotype 
differently. We identified three broad categories based 
on the number of phenotypic criteria used and measures 
used to operationalise those criteria. Those are Fried 
phenotype with five criteria—weakness and slowness 
assessed using objective tests, Fried phenotype with five 
criteria—weakness and slowness assessed using self-re-
ported questions (subjective) and Fried phenotype with 
only four criteria.
Prevalence of frailty and prefrailty
Irrespective of the frailty assessment method, the preva-
lence of frailty varied from 3.9% in China (Fried pheno-
type with five criteria—weakness and slowness assessed 
using objective tests) to 51.4% in Cuba (Cuban frailty 
criteria) and prevalence of prefrailty ranged from 13.4% 
in Tanzania (Brief Frailty Instrument for Tanzania, 
B-FIT) to 71.6% in Brazil (Fried phenotype with five 
criteria—weakness and slowness measured objectively) 
for the studies with minimum recruitment age 60, 65 and 
70 years. There was one study in those aged ≥90 years, 
reporting 61.8% participants as frail using the frailty 
index (not reported prefrailty). Another study with aged 
≥80 years had not reported a cut-off value for the frailty 
index to define frail participants. Instead, authors had 
reported six levels based on the value of the frailty index 
and the percentage of participants belongs to each level. 
The other study with aged ≥80 years reported 14.8% and 
63.8% participants as frail and prefrail, respectively, using 
Fried phenotype with five criteria—weakness and slow-
ness assessed using objective tests. When restricting to the 
studies that used Fried phenotype with five criteria and 
assessed the weakness and slowness objectively, the prev-
alence of frailty varied from 3.9% (China) to 26.0% in 
India. The prevalence of prefrailty varied from 40.7% to 
71.6% in Brazil.
Pooled prevalence of frailty and prefrailty
Descriptions of included studies in the meta-analysis are 
presented in table 1. Sixty-nine prevalence estimates 
(47 studies), corresponding to a total of 75 133 commu-
nity-dwelling older adults, were included in the frailty 
meta-analysis. The random-effects pooled prevalence 
of frailty in community-dwelling older adults was 17.4% 
(95% CI 14.4% to 20.7%). Cochran’s Q and I2 indi-
cated a high heterogeneity between included studies 
(Q=8756.8, df=68, P<0.001; I2=99.2%) (figure 2). Funnel 
plot asymmetry (figure 3) revealed evidence of reporting 
biases and/or between study heterogeneity. Results of 
Egger'sweighted regression test further confirmed the 
funnel plot asymmetry (P=0.042).
Fifty four prevalence estimates (42 studies) corre-
sponding to 47 302 participants were included in the 
prefrailty meta-analysis. The random-effects pooled prev-
alence of prefrailty in community-dwelling older adults 
was 49.3% (95% CI 46.4% to 52.2%). High heterogeneity 
was observed between included studies (Q=2082.6, df=53, 
P<0.001; I2=97.5%) (figure 4). Asymmetric funnel plot 
(figure 5) suggested the existence of reporting biases 
and/or between study heterogeneity. However, results 
of Egger's weighted regression test was insignificant indi-
cating no funnel plot asymmetry (P=0.817).
subgroup analyses
The pooled prevalence varied by the assessment method 
and the highest prevalence of frailty was reported for 
the EFS, 35.9% (95% CI 31.7% to 40.2%, I2=61.9%, 
P=0.022). The lowest prevalence of frailty was reported 
for the FRAIL scale, 12.4% (95% CI 8.4% to 17.1%). The 
pooled prevalence of frailty for the Fried phenotype with 
five criteria—weakness and slowness assessed using objec-
tive tests was 12.7% (95% CI 10.9% to 14.5%, I2=94.8%, 
P<0.001) (online supplementary appendix D). Results 
for pooled prevalence of prefrailty stratified by the frailty 
assessment method is presented in the online supplemen-
tary appendix D.
Twenty-four prevalence estimates were available from 
24 studies using the same assessment method (Fried 
Phenotype with objective tests) for sex-stratified analysis 
of prevalence of frailty and prefrailty. In total, there were 
10 507 and 15 458 male and female participants, respec-
tively. The pooled prevalence of frailty in men was 11.1% 
(95% CI 8.9% to 13.4%, I2=91.4%, P<0.001) compared 
with 15.2% (95% CI 12.5% to 18.1%, I2=95.2%, P<0.001) 
in women. Frailty prevalence was significantly higher in 
women compared with men (Z=−7.38, P<0.001). The 
pooled prevalence of prefrailty in men was 53.8% (95% 
CI 51.3% to 56.3%, I2=80.9%, P<0.001) and women was 
56.3% (95% CI 54.0% to 58.7%, I2=86.2%, P<0.001). 
Similar to frailty, there was a statistically significant sex 
difference in prefrailty (Z=−3.51, P<0.001).
The prevalence of frailty increased gradually with 
advancing age (online supplementary appendix E). The 
prevalence considerably increased after age of 75 years. 
The prevalence of prefrailty also slightly increased with 
advancing age and was >50% in all age groups. An age-re-
lated incremental rise in frailty was evident even after 
stratification by sex (online supplementary appendix F). 
Prevalence of frailty was higher in women in all 5-year age 
bands. There was no age-related trend for prefrailty after 
stratification by sex (online supplementary appendix G).
supplementary analysis
Ten prevalence estimates (10 studies), corresponding to 
a total of 27 660 community-dwelling older adults from 
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018195 on 1 March 2018. Downloaded from 
6 Siriwardhana DD, et al. BMJ Open 2018;8:e018195. doi:10.1136/bmjopen-2017-018195
Open Access 
Ta
b
le
 1
 
D
es
cr
ip
tio
ns
 o
f t
he
 s
tu
d
ie
s 
in
cl
ud
ed
 in
 t
he
 m
et
a-
an
al
ys
is
 o
f p
re
va
le
nc
e 
of
 fr
ai
lty
 a
nd
 p
re
fr
ai
lty
  
A
ut
ho
rs
 a
nd
 y
ea
r 
o
f 
p
ub
lic
at
io
n
C
o
un
tr
y
W
o
rl
d
 B
an
k 
re
g
io
n 
cl
as
si
fi
ca
ti
o
n
W
o
rl
d
 B
an
k 
in
co
m
e 
cl
as
si
fi
ca
ti
o
n
A
g
e 
(y
ea
rs
)
Fr
ai
lt
y 
as
se
ss
m
en
t 
m
et
ho
d
E
ff
ec
ti
ve
 s
am
p
le
P
re
va
le
nc
e 
(%
)
Fr
ai
lt
y
P
re
fr
ai
lt
y
Tr
ib
es
s 
et
 a
l, 
20
12
45
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
62
2
19
.9
49
.8
R
ei
s 
Jú
ni
or
 e
t 
al
, 2
01
44
6
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
28
6
23
.8
58
.7
P
eg
or
ar
i a
nd
 T
av
ar
es
, 2
01
44
7
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
95
8
12
.8
54
.5
S
an
to
s 
et
 a
l, 
20
15
48
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
13
6
16
.9
61
.8
C
lo
ss
 e
t 
al
, 2
01
64
9
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
52
1
21
.5
51
.1
M
el
lo
 e
t 
al
, 2
01
75
0
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
13
7
12
.4
61
.3
S
ou
sa
 e
t 
al
, 2
01
25
1
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
39
1
17
.1
60
.1
A
m
ar
al
 e
t 
al
, 2
01
35
2
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
29
5
18
.6
55
.3
M
or
ei
ra
 a
nd
 L
ou
re
nç
o,
 2
01
35
3
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
75
4
9.
5
47
.5
N
er
i e
t 
al
, 2
01
35
4  
(B
el
em
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
72
0
10
.8
48
.2
N
er
i e
t 
al
, 2
01
35
4  
(P
ar
na
ib
a)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
43
1
9.
7
55
.5
N
er
i e
t 
al
, 2
01
35
4  
(C
am
p
in
a 
G
ra
nd
e)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
39
5
8.
9
51
.4
N
er
i e
t 
al
, 2
01
35
4  
(P
oc
os
 d
e 
C
al
d
as
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
38
8
9.
3
53
.4
N
er
i e
t 
al
, 2
01
35
4  
(E
rm
el
in
o 
M
at
ar
az
zo
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
38
4
8.
1
54
.9
N
er
i e
t 
al
, 2
01
35
4  
(C
am
p
in
as
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
89
8
7.
7
52
.2
N
er
i e
t 
al
, 2
01
35
4  
(Iv
ot
i)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
19
7
8.
6
47
.7
V
ie
ira
 e
t 
al
, 2
01
35
5
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
60
1
8.
7
46
.3
R
ic
ci
 e
t 
al
, 2
01
45
6
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
76
1
9.
7
48
.0
C
on
tin
ue
d
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018195 on 1 March 2018. Downloaded from 
7Siriwardhana DD, et al. BMJ Open 2018;8:e018195. doi:10.1136/bmjopen-2017-018195
Open Access
A
ut
ho
rs
 a
nd
 y
ea
r 
o
f 
p
ub
lic
at
io
n
C
o
un
tr
y
W
o
rl
d
 B
an
k 
re
g
io
n 
cl
as
si
fi
ca
ti
o
n
W
o
rl
d
 B
an
k 
in
co
m
e 
cl
as
si
fi
ca
ti
o
n
A
g
e 
(y
ea
rs
)
Fr
ai
lt
y 
as
se
ss
m
en
t 
m
et
ho
d
E
ff
ec
ti
ve
 s
am
p
le
P
re
va
le
nc
e 
(%
)
Fr
ai
lt
y
P
re
fr
ai
lt
y
S
ilv
ei
ra
 e
t 
al
, 2
01
55
7
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
54
11
.1
46
.2
C
al
ad
o 
et
 a
l, 
2 
01
65
8
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
38
5
9.
1
49
.6
A
ug
us
ti 
et
 a
l, 
20
17
59
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
30
6
21
.5
71
.6
Fe
rr
io
lli
 e
t 
al
, 2
01
76
0  
(R
ec
ife
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
55
6
12
.1
66
.9
Fe
rr
io
lli
 e
t 
al
, 2
01
76
0  
(J
ui
z 
d
e 
Fo
ra
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
41
2
15
.5
63
.1
Fe
rr
io
lli
 e
t 
al
, 2
01
76
0  
(F
or
ta
le
za
)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
48
1
10
.4
63
.6
O
ca
m
p
o-
C
ha
p
ar
ro
 e
t 
al
, 
20
13
61
C
ol
om
b
ia
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
31
4
12
.7
71
.3
C
ur
ci
o 
et
 a
l, 
20
14
62
C
ol
om
b
ia
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
18
78
12
.2
53
.0
S
am
p
er
-T
er
ne
nt
 e
t 
al
, 2
01
66
3
C
ol
om
b
ia
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e 
*
14
42
9.
4
52
.4
S
án
ch
ez
-G
ar
cí
a 
et
 a
l, 
20
17
64
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
12
52
11
.2
50
.3
M
or
en
o-
Ta
m
ay
o 
et
 a
l, 
20
17
65
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥7
0
Fr
ie
d
 p
he
no
ty
p
e*
65
7
11
.9
51
.9
C
he
n 
et
 a
l, 
20
15
66
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
60
4
12
.7
56
.5
W
u 
et
 a
l, 
20
17
67
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
52
90
6.
3
51
.3
D
on
g 
et
 a
l, 
20
17
68
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
11
88
3.
9
45
.9
W
an
g 
et
 a
l, 
20
15
69
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
31
6
14
.2
49
.1
B
ad
ra
sa
w
i e
t 
al
, 2
01
77
0
M
al
ay
si
a
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e*
47
3
8.
9
61
.7
K
as
hi
ka
r 
an
d
 N
ag
ar
ka
r, 
20
16
32
In
d
ia
S
ou
th
 A
si
a
Lo
w
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
25
0
26
.0
63
.6
G
ur
in
a 
et
 a
l, 
20
11
71
R
us
si
a
E
ur
op
e 
an
d
 C
en
tr
al
 
A
si
a
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e*
61
1
21
.1
63
.0
A
lv
ar
ad
o 
et
 a
l, 
20
08
33
 (S
A
B
E
 
w
av
e 
1)
B
ar
b
ad
os
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
14
46
26
.7
54
.4
Ta
b
le
 1
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018195 on 1 March 2018. Downloaded from 
8 Siriwardhana DD, et al. BMJ Open 2018;8:e018195. doi:10.1136/bmjopen-2017-018195
Open Access 
A
ut
ho
rs
 a
nd
 y
ea
r 
o
f 
p
ub
lic
at
io
n
C
o
un
tr
y
W
o
rl
d
 B
an
k 
re
g
io
n 
cl
as
si
fi
ca
ti
o
n
W
o
rl
d
 B
an
k 
in
co
m
e 
cl
as
si
fi
ca
ti
o
n
A
g
e 
(y
ea
rs
)
Fr
ai
lt
y 
as
se
ss
m
en
t 
m
et
ho
d
E
ff
ec
ti
ve
 s
am
p
le
P
re
va
le
nc
e 
(%
)
Fr
ai
lt
y
P
re
fr
ai
lt
y
A
lv
ar
ad
o 
et
 a
l, 
20
08
33
 (S
A
B
E
 
w
av
e 
1)
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
18
79
40
.6
48
.8
A
lv
ar
ad
o 
et
 a
l, 
20
08
33
 (S
A
B
E
 
w
av
e 
1)
C
hi
le
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
12
20
42
.6
51
.4
A
lv
ar
ad
o 
et
 a
l, 
20
08
33
 (S
A
B
E
 
w
av
e 
1)
C
ub
a
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
17
26
39
.0
51
.6
A
lv
ar
ad
o 
et
 a
l, 
20
08
33
 (S
A
B
E
 
w
av
e 
1)
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
10
63
39
.5
49
.0
A
gu
ila
r-
N
av
ar
ro
 e
t 
al
, 2
01
57
2  
(M
H
A
S
 w
av
e 
1)
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e†
56
44
37
.2
51
.3
A
vi
la
-F
un
es
 e
t 
al
, 2
01
67
3
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥7
0
Fr
ie
d
 p
he
no
ty
p
e†
92
7
14
.1
37
.3
S
án
ch
ez
-G
ar
cí
a 
et
 a
l, 
20
14
74
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e‡
19
33
15
.7
33
.3
A
ki
n 
et
 a
l, 
20
15
75
 (K
E
H
E
S
)
Tu
rk
ey
E
ur
op
e 
an
d
 C
en
tr
al
 
A
si
a
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ie
d
 p
he
no
ty
p
e‡
 
84
8
27
.8
34
.8
Z
hu
 e
t 
al
, 2
01
67
6
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥7
0
Fr
ie
d
 p
he
no
ty
p
e‡
14
78
12
.0
42
.9
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
C
hi
na
 (u
rb
an
)
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
98
9
7.
8
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
C
hi
na
 (r
ur
al
)
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
10
02
8.
7
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
C
ub
a 
(u
rb
an
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
26
37
21
.0
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
D
om
in
ic
an
 
R
ep
ub
lic
 (u
rb
an
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
17
06
34
.6
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
In
d
ia
 (u
rb
an
)
S
ou
th
 A
si
a
Lo
w
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
74
8
11
.4
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
M
ex
ic
o 
(u
rb
an
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
90
9
10
.1
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
M
ex
ic
o 
(r
ur
al
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
93
3
8.
5
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
P
er
u 
(u
rb
an
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
12
45
25
.9
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
P
er
u 
(r
ur
al
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
50
7
17
.2
– 
Jo
th
ee
sw
ar
an
 e
t 
al
, 2
01
53
1
Ve
ne
zu
el
a 
(u
rb
an
)
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ie
d
 p
he
no
ty
p
e‡
16
97
11
.0
– 
Ta
b
le
 1
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018195 on 1 March 2018. Downloaded from 
9Siriwardhana DD, et al. BMJ Open 2018;8:e018195. doi:10.1136/bmjopen-2017-018195
Open Access
A
ut
ho
rs
 a
nd
 y
ea
r 
o
f 
p
ub
lic
at
io
n
C
o
un
tr
y
W
o
rl
d
 B
an
k 
re
g
io
n 
cl
as
si
fi
ca
ti
o
n
W
o
rl
d
 B
an
k 
in
co
m
e 
cl
as
si
fi
ca
ti
o
n
A
g
e 
(y
ea
rs
)
Fr
ai
lt
y 
as
se
ss
m
en
t 
m
et
ho
d
E
ff
ec
ti
ve
 s
am
p
le
P
re
va
le
nc
e 
(%
)
Fr
ai
lt
y
P
re
fr
ai
lt
y
Fh
on
 e
t 
al
, 2
01
27
7
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
E
FS
24
0
39
.2
24
.6
A
gr
el
i e
t 
al
, 2
01
37
8
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
E
FS
10
3
30
.1
22
.3
D
ua
rt
e 
et
 a
l, 
20
13
79
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
E
FS
16
6
39
.2
21
.7
D
el
 B
ru
tt
o 
et
 a
l, 
20
16
80
E
cu
ad
or
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
E
FS
29
8
31
.2
22
.0
Fa
b
ríc
io
-W
eh
b
e 
et
 a
l, 
20
09
81
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
E
FS
13
7
31
.4
20
.4
C
ar
ne
iro
 e
t 
al
, 2
01
68
2
B
ra
zi
l
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
E
FS
51
1
41
.3
– 
W
oo
 e
t 
al
, 2
01
54
2
C
hi
na
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
Fr
ai
lty
 in
d
ex
63
20
 (u
rb
an
)
97
8 
(r
ur
al
)
17
.0
5.
2
– – 
S
at
ha
si
va
m
 e
t 
al
, 2
01
54
3
M
al
ay
si
a
E
as
t 
A
si
a 
an
d
 
P
ac
ifi
c
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ai
lty
 in
d
ex
78
9
5.
7
67
.7
P
ér
ez
-Z
ep
ed
a 
et
 a
l, 
20
16
44
M
ex
ic
o
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
Fr
ai
lty
 in
d
ex
71
08
45
.2
– 
G
al
b
án
 e
t 
al
, 2
00
98
3
C
ub
a
La
tin
 A
m
er
ic
a 
an
d
 
th
e 
C
ar
ib
b
ea
n
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
0
C
ub
an
 fr
ai
lty
 c
rit
er
ia
54
1
51
.4
– 
B
ou
lo
s 
et
 a
l, 
20
16
84
Le
b
an
on
M
id
d
le
 E
as
t 
an
d
 
N
or
th
 A
fr
ic
a
U
p
p
er
 m
id
d
le
 in
co
m
e
≥6
5
S
O
F 
fr
ai
lty
 in
d
ex
11
20
36
.4
30
.4
G
ra
y 
et
 a
l, 
20
17
30
Ta
nz
an
ia
S
ub
-S
ah
ar
an
 A
fr
ic
a
Lo
w
 in
co
m
e
≥7
0
B
-F
IT
94
1
4.
6
13
.4
*F
rie
d
 P
he
no
ty
p
e 
w
ith
 fi
ve
 c
rit
er
ia
—
w
ea
kn
es
s 
an
d
 s
lo
w
ne
ss
 a
ss
es
se
d
 u
si
ng
 o
b
je
ct
iv
e 
te
st
s.
†F
rie
d
 P
he
no
ty
p
e 
w
ith
 fi
ve
 c
rit
er
ia
—
w
ea
kn
es
s 
an
d
 s
lo
w
ne
ss
 a
ss
es
se
d
 u
si
ng
 s
el
f-
re
p
or
te
d
 q
ue
st
io
ns
 (s
ub
je
ct
iv
e)
.
‡F
rie
d
 p
he
no
ty
p
e 
w
ith
 fo
ur
 c
rit
er
ia
.
B
-F
IT
, B
rie
f F
ra
ilt
y 
In
st
ru
m
en
t 
fo
r 
Ta
nz
an
ia
; E
FS
, E
d
m
on
to
n 
Fr
ai
l S
ca
le
; K
E
H
E
S
, K
ay
se
ri 
E
ld
er
ly
 H
ea
lth
 S
tu
d
y;
 M
H
A
S
, M
ex
ic
an
 H
ea
lth
 a
nd
 A
gi
ng
 S
tu
d
y;
 S
A
B
E
-H
ea
lth
, W
el
lb
ei
ng
 a
nd
 
A
ge
in
g 
S
tu
d
y;
 S
O
F,
 S
tu
d
y 
of
 O
st
eo
p
or
ot
ic
 F
ra
ct
ur
es
 fr
ai
lty
 in
d
ex
.
Ta
b
le
 1
 
C
on
tin
ue
d
 
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018195 on 1 March 2018. Downloaded from 
10 Siriwardhana DD, et al. BMJ Open 2018;8:e018195. doi:10.1136/bmjopen-2017-018195
Open Access 
HICs and 21 prevalence estimates (13 studies), corre-
sponding to a total of 9586 community-dwelling older 
adults from middle-income countries, were included 
in the frailty meta-analysis. The random-effects pooled 
prevalence of frailty in community-dwelling older adults 
in HICs and middle-income countries were 8.2% (95% 
CI 5.7% to 11.2%) (online supplementary appendix H) 
and 12.3% (95% CI 10.4% to 14.4%) (online supplemen-
tary appendix I), respectively. The prevalence of frailty 
in older adults from middle-income countries was signifi-
cantly higher compared with the older adults residing 
in HICs, (Z=−8.86, P<0.001). However, it is also of note 
that studies included in the meta-analysis of HICs were 
predominantly from the USA whereas studies included 
in the middle-income countries meta-analysis were 
predominantly from Brazil and all the countries belong 
to upper middle-income category except one study from 
India. The pooled prevalence of frailty except the study 
from India was 11.8% (95% CI 10.0% to 13.6%) and still 
significantly higher compared with HICs.
The random-effects pooled prevalence of prefrailty in 
community-dwelling older adults in HICs and middle-in-
come countries were correspondingly 43.9% (95% CI 
40.9% to 46.9%) (online supplementary appendix J) and 
55.3% (95% CI 52.0% to 58.6%) (online supplementary 
appendix K). Like frailty, prevalence of prefrailty also 
Figure 2 Random-effects pooled prevalence of frailty among community-dwelling older adults in LMICs. ES, effect size; 
LMICs, low-income and middle-income countries. 
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significantly higher among the older adults in middle-in-
come countries compared with the higher income coun-
tries (Z=−17.14, P<0.001).
Meta-regression
After adjusting for all the other study characteristics in 
a multivariable meta-regression model, there remained 
statistically significant differences in frailty prevalence 
between different assessment methods. Use of EFS, frailty 
index and Fried phenotype (five criteria, weakness and 
slowness assessed using self-reported questions (subjec-
tive)) was associated with a frailty prevalence approxi-
mately 20% higher than the reference method (Fried 
phenotype five criteria with objective tests). Geographic 
region was also a statistically significant predictor of 
frailty. The variables included in the multivariable model 
(mean age, % of women in the sample, study quality 
assessment score, geographic region and frailty assess-
ment method) explained 58.4% of variability between the 
studies included in the analysis (table 2).
DIsCussIOn
summary of main findings
Only one epidemiological study on frailty was found from 
countries with low-income economies30 (≤US$1005) 
according to World Bank Classification, 2017.19 Of coun-
tries with lower middle-income economies (US$1006–
US$3955) we only found two studies both from India. One 
was a study site of a multicountry study31 and the other one 
was a small community-based cross-sectional study.32 All 
the other studies have been conducted in countries with 
upper middle-income economies (US$3956–US$12 235) 
indicating income inequality in frailty research.
The random-effects pooled prevalence of frailty and 
prefrailty in community-dwelling older adults were 17.4% 
(95% CI 14.4% to 20.7%) and 49.3% (95% CI 46.4% to 
52.2%), respectively. Frailty was significantly higher in 
women compared with men and as expected increased 
with age. This finding is consistent with previous 
research.15 33–36 Interestingly, the prevalence of prefrailty 
was also slightly increasing across all age groups at around 
half the participants. Both the prevalence of frailty and 
prefrailty appeared significantly higher in communi-
ty-dwelling older adults in upper middle-income coun-
tries compared with HICs.
Comparison with the existing literature
The pooled prevalence of frailty and prefrailty in LMICs 
in this review appeared to be higher than the weighted 
prevalence in HICs reported previously (10.7%, (95% CI 
10.5% to 10.9%) and 41.6% (95% CI 41.2% to 42.0%), 
respectively).15 However, it is also of note that the partic-
ipants in HICs included people aged ≥65 years, whereas 
50% of studies in our meta-analysis included participants 
aged ≥60 years. Given that prevalence of frailty increases 
with age, when participants of a higher age group are 
selected, a higher prevalence would be expected. Our 
meta-analysis included 18 studies (36 estimates) with a 
population aged ≥65 years. The prevalence of frailty of 
this subsample was 14.6% (95% CI 11.9% to 17.4%) and 
still higher compared with HICs. In the review of frailty in 
HICs, most studies were from Europe and North America. 
Figure 3 Funnel plot for assessing publication or other types of biases in meta-analysis of prevalence of frailty. ES, effect size.
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Studies included in our review were predominantly from 
Latin America and the Caribbean and belong to the 
countries with upper middle-income economies, with 
little representation of lower middle-income and low-in-
come countries. A recent meta-analysis in Latin America 
and Caribbean showed consistent findings to our study, 
with nearly one out of five older adult defined as frail.37
We found lower prevalence rates when we restricted the 
meta-analysis only to the Fried phenotype with five criteria, 
including objective measures of weakness and slowness. 
This found a pooled prevalence of frailty of 12.7% and 
prefrailty of 55.2%. The review on frailty and prefrailty 
which included only HICs has simply reported the weighted 
prevalence of frailty and prefrailty.15 Given the heteroge-
neity of the studies along with the actual differences of 
frailty estimates in different populations, we performed 
a supplementary analysis for a fair comparison of frailty 
estimates between HICs and middle-income countries (no 
studies were available from low-income countries using the 
same frailty assessment method). Results indicated signifi-
cantly higher prevalence of frailty and prefrailty among 
community-dwelling older adults in middle-income coun-
tries compared with the HICs. Another review of the prev-
alence of frailty measured by the Fried phenotype based 
on community-dwelling older adults ≥ 65 years in nation-
ally representative samples reported lower prevalence to 
our estimate except in the countries of Southern Europe 
(France, Italy, Greece and Spain).38 Lower prevalence of 
frailty is also observed in high-income Asian countries 
(Japan, Singapore and Taiwan).36 39–41
Figure 4 Random-effects pooled prevalence of prefrailty among community-dwelling older adults in LMICs. ES, effect size; 
LMICs, low-income and middle-income countries.  o
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In contrast to these findings, a single multicountry 
study conducted with data from 14 HICs in Europe and 
six LMICs (China, Ghana, India, Mexico, Russian Feder-
ation and South Africa) reported higher frailty level 
(high mean frailty index) in HICs compared with the 
low-income countries.34 This study included nationally 
representative samples of adults aged ≥50 years. They 
also found an inverse association between level of frailty 
and income and education in both HICs and low-in-
come countries. Individuals with poor education and 
low income were more likely to be frail. Higher levels of 
frailty in HICs could be due to the higher survival rate of 
participants with advanced healthcare and social protec-
tion. On the other hand, as the frailty index is based 
on a list of deficits including diagnosed diseases, many 
medical conditions could be under reported/diagnosed 
in the participants in LMICs. Similarly, in most LMICs 
where access to continued care is lacking, maintenance of 
medical records are poor making it difficult to use cumu-
lative deficit models.
In our study, even among the studies using Fried 
phenotype with objective criteria, there was considerable 
variation in operationalising the five phenotypic criteria. 
Furthermore, the approach to deriving frail cut-offs for 
weakness, slowness and physical activity criteria were 
varied. Of thirty studies, 17 have calculated their popu-
lation specific cut-offs based on the anthropometry of 
their own study populations. Eight studies have used the 
cut-offs developed by Fried et al in the Cardiovascular 
Health Study (CHS).4 The pooled prevalence of frailty is 
higher with the studies that used CHS cut-offs compared 
with the studies that used own population specific 
cut-offs. However, the pooled prevalence of prefrailty was 
similar in both groups. Similarly, the number of deficits 
used in frailty index and cut-off points for defining frailty 
and prefrailty status were inconsistent.42–44 A further 
meta-analysis with all available studies including both 
higher and the lower and middle-income countries would 
be valuable, controlling for frailty assessment method, sex 
and age composition of the sample. In addition, meth-
odologically comparable studies across countries are 
required to study the true population difference of frailty.
strengths and weaknesses
This is the first systematic review and meta-analysis on 
prevalence of frailty and prefrailty among communi-
ty-dwelling older adults in LMICs. The strengths of our 
study include we conducted a comprehensive literature 
search in six electronic databases with a comprehensive 
search strategy, including WHO Global Health library 
to capture studies published regionally. No language 
restriction, subgroup analysis of prevalence of frailty and 
prefrailty with substantial number of studies, and using 
a meta-regression technique to identify the sources of 
heterogeneity between the studies, contacting authors to 
get the additional information of the studies required for 
subgroup analyses were also strengths.
Both funnel plot asymmetry and the results of the 
Egger's weighted regression test indicated the presence 
of reporting biases and/or between study heterogeneity 
in the random-effects meta-analysis of frailty. The nature 
of our study effect (prevalence) is unlikely to be affected 
by publication bias. However, publication bias could also 
be affected by study size, funding source or research 
Figure 5 Funnel plot for assessing publication or other types of biases in meta-analysis of prevalence of prefrailty. ES, effect 
size.
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group.27 We noted that majority of the studies included 
in our meta-analysis have large samples. Multiple sources 
have been identified that could affect funnel plot asym-
metry including reporting biases (publication bias, selec-
tive outcome reporting and selective analysis reporting), 
poor methodological quality, true heterogeneity, arte-
factual and chance.25 26 In our case, we believe that the 
funnel plot asymmetry is mainly due to the true hetero-
geneity between the studies mainly because of the use 
of different frailty assessment methods. And also, it is 
possible to have a true underlying difference of frailty 
prevalence in different populations. Another limitation 
of this study was non-inclusion of grey literature.
Implications for practice
The findings of the study suggest that the prevalence of 
frailty appears higher among community-dwelling older 
adults in upper middle-income countries compared with 
HICs. One study was identified from low-income coun-
tries and two studies from a lower middle-income country. 
Despite evidence that populations are rapidly ageing in 
many of these countries, we do not currently know the 
prevalence of frailty in these populations to inform health 
and social care planning. Research is required from 
low-income and lower middle-income countries with 
rapidly ageing populations to estimate burden of frailty 
and to understand how frailty affects the day-to-day lives 
of older people. Furthermore, a consensus is required 
on methods of assessing frailty to allow for more robust 
comparisons across populations.
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